Add Yahoo as a preferred source to see more of our stories on Google. April 9 (UPI) --Eli Lilly announced that its GLP-1 weight-loss pill is available for purchase in the United States starting ...

Severe ankle pain drove Jelon Smart to start taking a weight loss injection a year and a half ago. Smart was 285 pounds and worked as a caterer in Savannah, Georgia. After she’d been standing on her ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major caveat: They don’t work for everyone. Some people experience profound ...

Matthew Herper covers medical innovation — both its promise and its perils. Specific changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs used to ...

The online health platform Hers has launched a new weight loss membership for GLP-1 treatments. The membership starts at $39 for the first month and then costs $149 per month. Hers offers various ...

Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight and boost health. About 1 in 8 U.S. adults say they are taking a GLP-1 drug ...

SINCE 2000. THERE’S A NEW REPORT THAT’S OUT TONIGHT THAT FINDS THAT WOMEN ARE LOSING MORE WEIGHT WITH GLP ONES THAN MEN. SO HERE TO ANSWER THAT, JUST TO TALK ABOUT IT, DOCTOR TODD ELLEN FROM SOUTH ...

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. The orforglipron pill, called ...

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

You’re not imagining it: GLP-1 receptor agonist medications—like Ozempic, Wegovy, and Zepbound—really are that ubiquitous. Nearly one in five American adults has taken this type of drug at some point, ...